ORCL

Lobbying Update: $90,000 of ORACLE CORPORATION lobbying was just disclosed

$90,000 of ORACLE CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Cloud Computing, Cybersecurity, Export Control related to Artificial Intelligence, Electronic Health Records, H.R.5009 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025, H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025, S.4638 - National Defense Authorization Act for Fiscal Year 2025
Department of Veterans Affairs Adoption of Electronic Health Records"

You can find more data on corporate lobbying on Quiver Quantitative.

ORCL Congressional Stock Trading

Members of Congress have traded $ORCL stock 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ORCL Insider Trading Activity

ORCL insiders have traded $ORCL stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ORCL Hedge Fund Activity

We have seen 1,397 institutional investors add shares of ORCL stock to their portfolio, and 1,179 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.


This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.